“…Previously, epidemiological studies established correlations between OPs and endocrine system diseases [8,9,10] or infertility [11,12] based on urinary measurements of DEP. The endocrine-disrupting effects of OPs, including chlorpyrifos [13,14,15,16,17,18], diazinon [19,20], malathion [21], triazophos [22], and dimethoate [23], have only been proven in animal studies, which reported a disorder of hormones involved in the hypothalamic‒pituitary‒adrenal [20], hypothalamic‒pituitary‒thyroid [14,17,18,19], and hypothalamic‒pituitary‒gonadal axes [14,15,16,17,21,22,23]. All of these OPs metabolize to DEP in vivo; however, we do not know whether these effects are induced by the parent OPs or the metabolites, especially the non-specific metabolite, DEP.…”